These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23802234)

  • 1. Developments in the use of nanocapsules in oncology.
    Yurgel V; Collares T; Seixas F
    Braz J Med Biol Res; 2013 Jun; 46(6):486-501. PubMed ID: 23802234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology based targeted drug delivery.
    Ruggiero C; Pastorino L; Herrera OL
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():3731-2. PubMed ID: 21096863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
    Erdoğar N; Akkın S; Bilensoy E
    Recent Pat Drug Deliv Formul; 2018; 12(4):252-266. PubMed ID: 30674269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
    Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
    J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward therapeutic delivery with layer-by-layer engineered particles.
    Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
    ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanooncology in ovarian cancer treatment.
    Kasprzak B; Miskiel S; Markowska J
    Eur J Gynaecol Oncol; 2016; 37(2):161-3. PubMed ID: 27172737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Themed issue on Cancer Nanotechnology.
    Grodzinski P
    Integr Biol (Camb); 2013 Jan; 5(1):17-8. PubMed ID: 23179042
    [No Abstract]   [Full Text] [Related]  

  • 13. Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo.
    Klippstein R; Wang JT; El-Gogary RI; Bai J; Mustafa F; Rubio N; Bansal S; Al-Jamal WT; Al-Jamal KT
    Small; 2015 Sep; 11(36):4704-22. PubMed ID: 26140363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on current and potential nanoparticle cancer therapies.
    Rink JS; Plebanek MP; Tripathy S; Thaxton CS
    Curr Opin Oncol; 2013 Nov; 25(6):646-51. PubMed ID: 24097107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine in veterinary oncology.
    Lin TY; Rodriguez CO; Li Y
    Vet J; 2015 Aug; 205(2):189-97. PubMed ID: 25862394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of chlorin e6 and doxorubicin using PEGylated hollow nanocapsules for 'all-in-one' tumor theranostics.
    Li Q; Hou M; Ren J; Lu S; Xu Z; Li CM; Kang Y; Xue P
    Nanomedicine (Lond); 2019 Sep; 14(17):2273-2292. PubMed ID: 31414615
    [No Abstract]   [Full Text] [Related]  

  • 18. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting liposomal nanomedicine to cancer therapy.
    Zhong J; Dai LC
    Technol Cancer Res Treat; 2012 Oct; 11(5):475-81. PubMed ID: 22475065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.